Activation of the hypothalamo-hypophyseal-adrenocortical system as an important gastroprotective component of the stress reaction

Neuroscience and Behavioral Physiology

Volumn 37, Issue 4, 2007, Pages 355-362

  Filaretova, L P ^a  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

Author keywords

Gastric erosions and ulcers; Gastroprotection; Glucocorticoid hormones; Hypothalamo hypophyseal adrenocortical system; Stress; Ulcerogenic stimuli

Indexed keywords

CAPSAICIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; NITRIC OXIDE; PROSTAGLANDIN;

ARTICLE; DATA ANALYSIS; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL; NONHUMAN; STOMACH MUCOSA; STOMACH PROTECTION; STRESS; ULCEROGENESIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTRIC MUCOSA; GLUCOCORTICOIDS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOMETHACIN; PITUITARY-ADRENAL SYSTEM; RATS; STRESS, PSYCHOLOGICAL;

EID: 34247567493     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0021-8     Document Type: Article

References (50)

1. T. T. Podvigina, A. I. Bogdanov, and L. P. Filaretova, "The role of glucocorticoids in the healing of indomethacin-induced gastric mucous erosions in rats," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 6, 720-727 (2000).
2. G. Sel'e, At the Level of the Whole Body [in Russian], Nauka, Moscow (1972).
3. A. A. Filaretov, T. T. Podvigina, and L.P. Filaretova, Adaptation as a Function of the Hypophyseal-Adrenocortical System (Monograph) [in Russian], Nauka, St. Petersburg (1994).
4. L. P. Filaretova, "The role of the paraventricular nucleus of the hypothalamus in the inhibition of the hypophyseal-adrenocortical system," Dokl. Akad. Nauk., 273, No. 1, 247-250 (1983).
5. L. P. Filaretova, "Relationship between the formation of gastric stress ulcers and the state of the hypothalamo-hypophyseal-adrenocortical system," Ros. Fiziol. Zh. im. I. M. Sechenova, 76, No. 11, 1594-1600 (1990).
6. L. P. Filaretova, "Gastric stress ulcers: The protective role of hypothalamo-hypophyseal-adrenocortical system hormones," Ros. Fiziol. Zh. im. I. M. Sechenova, 81, No. 3, 52-62 (1995).
7. L. P. Filaretova, "Glucocorticoid hormones as important protective factors for the gastric mucosa," in: St. Petersburg Fragments of the Scientific World View [in Russian], E. A. Ivanova, Yu. A. Petrosyan, and É. A. Tropp (eds.), St. Petersburg Scientific Center, Russian Academy of Sciences, St. Petersburg, No. 2, pp. 169-177 (2003).
8. L. P. Filaretova, "The role of endogenous glucocorticoids in maintaining the integrity of the gastric mucosa," Ros. Fiziol. Zh. im. I. M. Sechenova, 86, No. 11, 1548-1558 (2000).
9. L. P. Filaretova and Yu. I. Levkovich, "The antiulcer effect of corticosteroids and the blood supply of the gastric mucosa," Ros. Fiziol. Zh. im. I. M. Sechenova, 82, No. 2, 63-72 (1996).
10. L. P. Filaretova and A. A. Filaretov, "The effects of large doses of corticosteroids on ulcer formation in the stomach: A new hypothesis," Ros. Fiziol. Zh. im. I. M. Sechenova, 78, No. 10, 77-83 (1992).
11. L. P. Filaretova, T. R. Bagaeva, T. T. Podvigina, and O. Yu. Morozova, "Deficiency of glucocorticoid production in rats increases the ulcerogenic effects of stimuli of different modalities and intensities," Ros. Fiziol. Zh. im. I. M. Sechenova, 88, No. 5, 602-611 (2002).
12. L. P. Filaretova, T. R. Bagaeva, T. T. Podvigina, and O. Yu. Morozova, "Deficiency of glucocorticoid production slows the healing of acute erosions and chronic ulcers of the gastric mucosa in rats," Ros. Fiziol. Zh. im. I. M. Sechenova, 89, No. 9, 1137-1146 (2003).
13. H. E. Black, "The effects of steroids upon the gastrointestinal tract," Toxicol. Pathol., 16, No. 2, 213-222 (1988).
14. A. Dembinski, Z. Warzecha, P. Ceranowicz, T. Brzozowski, M. Dembinski, S. J. Konturek, and W. W. Pawlik, "Role of capsaicin-sensitive nerves and histamine H1, H2, and H3 receptors in the gastroprotective effect of histamine against stress ulcers in rats," Eur. J. Pharmacol., 508, No. 1-3, 211-221 (2004).
15. K. Ehrlich, C. Sicking, M. Respondek, and B. Peskar, "Interaction of cyclooxygenase isoenzymes, nitric oxide, and afferent neurons in gastric mucosal defence in rats," J. Pharmacol. Exptl. Ther., 256, No. 1, 441-447 (2004).
16. A. A. Filaretov and L. P. Filaretova, "Role of the paraventricular and ventromedial hypothalamic nuclear areas in the regulation of the pituitary-adrenocortical system," Brain Res., 342, No. 1, 135-140 (1985).
17. L. P. Filaretova, "The hypothalamic-pituitary-adrenocortical system: Hormonal brain-gut interaction and gastroprotection," Autonom. Neurosci. (2005) (in press).
18. L. P. Filaretova, T. R. Bagaeva, and G. B. Makara, "Aggravation of nonsteroidal antiinflammatory drug gastropathy by glucocorticoid deficiency or blockade of glucocorticoid receptor in rats," Life Sci., 71, No. 21, 2457-2468 (2002).
19. L. P. Filaretova, T. R. Bagaeva, and T. T. Podvigina, "Role of endogenous glucocorticoids in the healing of gastric erosions and chronic gastric ulcers in rats," Inflammopharmacology, 10, No. 4-6, 401-412 (2002).
20. L. P. Filaretova, A. A. Filaretov, and G. B. Makara, "Corticosterone increase inhibits stress-induced gastric erosions in rats," Amer. J. Physiol., 274, No. 37, G1024-G1030 (1998).
21. L. P. Filaretova, T. R. Bagaeva, T. T. Podvigina, and G. B. Makara, "Various ulcerogenic stimuli are potentiated by glucocorticoid deficiency in rat," J. Physiol. (Paris), 95, No. 1-6, 59-65 (2001).
22. L. P. Filaretova, A. N. Maltcev, A. I. Bogdanov, and A. I. Levkovich, "Role of gastric microcirculation in the gastroprotection by glucocorticoids released during water-restraint stress in rats," Clin. J. Physiol., 42, No. 3, 145-152 (1999).
23. L. P. Filaretova, T. T. Podvigina, T. R. Bagaeva, and G. B. Makara, "Gastroprotective action of glucocorticoids during the formation and the healing of indomethacin-induced gastric erosions in rats," J. Physiol. (Paris), 95, No. 1-6, 201-208 (2001).
24. L. Filaretova, A. Tanaka, S. Kato, and K. Takeuchi, "The mechanisms of gastroprotective action of glucocorticoids against indomethacin-induced gastric mucosal injury," Ulcer Res. (Japan), 29, No. 2, 159-162 (2002).
25. L. Filaretova, A. Tanaka, Y. Komoike, and K. Takeuchi, "Selective cyclooxygenase-2_inhibitor induces gastric mucosal damage in adrenalectomized rats," Inflammopharmacology, 10, No. 4-6, 413-422 (2002).
26. L. Filaretova, P. Bobryshev, T. Bagaeva, T. Podvigina, and K. Takeuchi, "Compensatory role of glucocorticoid hormones in gastric mucosal defense under inhibition of prostaglandin and nitric oxide production or desensitization of capsaicin-sensitive afferent neurons in rats," Gastroenterology, 128, No. 4, Supplement 2, A-343 (2005).
27. L. P. Filaretova, T. T. Podvigina, T. R. Bagaeva, G. Makara, and K. Tekeuchi, "Hormonal mechanisms of gastroprotection: Role of the hypothalamic-pituitary-adrenocortical axis," in: Mediators in Gastrointestinal Protection and Repair, K. Takeuchi and G. Mozsik (eds.), Res. Signpost, Kerala (2004), pp. 17-41.
28. L. P. Filaretova, T. T. Podvigina, T. R. Bagaeva, A. Tanaka, and K. Takeuchi, "Mechanisms underlying gastroprotective action of glucocorticoids released in response to ulcerogenic stress factors," Ann. N.Y. Acad. Sci., 1018, No. 1-5, 288-293 (2004).
29. L. P. Filaretova, T. T. Podvigina, T. R. Bagaeva, A. Tanaka, and K. Takeuchi, "Gastroprotective action of glucocorticoid hormones during NSAID treatment," Inflammopharmacology, 13, No. 1-3, 27-43 (2005).
30. L. Filaretova, A. Tanaka, S. Kato, T. Miyazawa, and K. Takeuchi, "Mechanisms underlying protective action of endogenous glucocorticoids against indomethacin induced gastric injury in rats," Amer. J. Physiol., 283, No. 5, G1082-G1089 102.
31. L. Filaretova, T. Podvigina, T. Bagaeva, P. Bobryshev, A. Tanaka, and K. Takeuchi, "Cooperative interaction between glucocorticoids and prostaglandins in gastroprotection," in: International Proceedings of the llth International Conference on Ulcer Research, P. Sikiric (ed.), Monduzzi, Italy (2003), pp. 169-173.
32. S. J. Gray, C. Ramsey, R. W. Reifenstein, and J. A. Benson, "The significance of hormonal factors in the pathogenesis of peptic ulcer," Gastroenterology, 25, No. 2, 156-172 (1953).
33. K. Gyires, "Gastric mucosal protection: From prostaglandins to gene therapy," Curr. Med. Chem., 12, No. 2, 203-215 (2005).
34. C. J. Hawkey, "Nonsteroidal anti-inflammatory drug gastropathy," Gastroenterology, 119, No. 2, 521-535 (2000).
35. P. Holzer, "Neural emergency system in the stomach," Gastroenterology, 114, No. 4, 823-839 (1998).
36. F. Lechin, B. van der Dijs, I. Rada, J. Jara, A. E. Lechin, A. Cabrera, M. E. Lechin, C. Jimenez, F. Gomez, and S. Villa, "Plasma neurotransmitters and cortisol in duodenal ulcer patients. Role of stress," Dig. Dis. Sci., 35, No. 11, 1313-1319 (1990).
37. R. Murison, J. B. Overmier, D. H. Hellhammer, and M. Carmona, "Hypothalamo-pituitary-adrenal manipulations and stress ulcerations in rats," Psychoneuroendocrinology, 14, No. 5, 331-338 (1989).
38. H. M. Murphy, C. H. Wideman, and T. S. Brown, "Plasma corticosterone levels and ulcer formation in rats with hippocampal lesions," Neuroendocrinology, 28, No. 2, 123-130 (1979).
39. M. Perretti, K. G. Mugridge, J. L. Wallace, and L. Parente, "Reduction of aspirin-induced gastric damage in rats by interleukin-1 beta: Possible involvement of endogenous corticosteroids," J. Pharmacol. Exptl. Ther., 261, No. 3, 1238-1247 (1992).
40. D. J. Sandweiss, "Effects of adrenocorticotrophic hormone (ACTH) and of cortisone on peptic ulcer. I. Clinical review," Gastroenterology, 27, No. 5, 604-616 (1954).
41. M. J. Spirt, "Stress-related mucosal disease: Risk factors and prophylactic therapy," Clin. Ther., 26, No. 2, 197-213 (2004).
42. N. Stollman and D. C. Metz, "Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients," J. Crit. Care, 20, No. 1, 35-45 (2005).
43. S. Szabo, G. T. Gallagher, H. C. Horner, P. W. Frankel, R. H. Underwood, S. J. Konturek, T. Brzozowski, and J. S. Trier, "Role of the adrenal cortex in gastric mucosal protection by prostaglandins, sulfhydryls, and cimetidine in the rat," Gastroenterology, 85, No. 6, 1384-1390 (1983).
44. K. Takeuchi, A. Tanaka, K. Suzuki, and H. Mizoguchi, "Gastrointestinal sparing anti-inflammatory drugs-effects on ulcerogenic and healing responses," Curr. Pharm. Des., 7, 49-69 (2001).
45. J. R. Vane, "Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs," Nat New Biol., 231, No. 25, 232-235 (1971).
46. J. R. Vane and R. M. Botting, "The mechanism of action of aspirin," Thromb. Res., 110, No. 5-6, 255-258 (2003).
47. J. L. Wallace, "Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years," Gastroenterology, 112, No. 3, 1000-1016 (1997).
48. J. M. Weiss, "Effects of coping behavior in different warning signal conditions on stress pathology in rats," J. Comp. Physiol. Psychol., 77, No. 1, 1-13 (1971).
49. B. L. Weusten, J. W. Jacobs, and J. M. Bijlsma, "Corticosteroid pulse therapy in active rheumatoid arthritis," Semin. Arthr. Rheum., 23, No. 3, 183-192 (1993).
50. B. J. R. Whittle, J. Lopez-Belmonte, and S. Moncada, "Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat," Brit. J. Pharmacol., 99, No. 3, 606-611 (1990).